163 related articles for article (PubMed ID: 16206181)
1. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Synapse; 2005 Dec; 58(4):229-35. PubMed ID: 16206181
[TBL] [Abstract][Full Text] [Related]
2. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
[TBL] [Abstract][Full Text] [Related]
3. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat.
Nair SG; Gudelsky GA
Synapse; 2004 Sep; 53(4):202-7. PubMed ID: 15266551
[TBL] [Abstract][Full Text] [Related]
4. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat.
Nair SG; Gudelsky GA
Psychopharmacology (Berl); 2006 Jan; 184(2):182-9. PubMed ID: 16378215
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
Nair SG; Gudelsky GA
Brain Res; 2004 Jul; 1013(2):168-73. PubMed ID: 15193525
[TBL] [Abstract][Full Text] [Related]
7. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
Bankson MG; Yamamoto BK
J Neurochem; 2004 Nov; 91(4):852-9. PubMed ID: 15525339
[TBL] [Abstract][Full Text] [Related]
8. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
Ramos M; Goñi-Allo B; Aguirre N
Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
[TBL] [Abstract][Full Text] [Related]
9. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.
Laplante F; Stevenson CW; Gratton A; Srivastava LK; Quirion R
J Neurochem; 2004 Dec; 91(6):1473-82. PubMed ID: 15584923
[TBL] [Abstract][Full Text] [Related]
10. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions.
Laplante F; Srivastava LK; Quirion R
J Neurochem; 2004 Apr; 89(2):314-23. PubMed ID: 15056275
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Pisanu A; Acquas E; Fenu S; Di Chiara G
Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
[TBL] [Abstract][Full Text] [Related]
12. Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.
Sato M; Ago Y; Koda K; Nakamura S; Kawasaki T; Baba A; Matsuda T
Eur J Pharmacol; 2007 Mar; 559(2-3):155-60. PubMed ID: 17258195
[TBL] [Abstract][Full Text] [Related]
13. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
Prus AJ; Huang M; Li Z; Dai J; Meltzer HY
Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654
[TBL] [Abstract][Full Text] [Related]
14. Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT 1B receptors.
Consolo S; Arnaboldi S; Ramponi S; Nannini L; Ladinsky H; Baldi G
J Pharmacol Exp Ther; 1996 May; 277(2):823-30. PubMed ID: 8627564
[TBL] [Abstract][Full Text] [Related]
15. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
Morley KC; Arnold JC; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
[TBL] [Abstract][Full Text] [Related]
16. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
17. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
Acquas E; Wilson C; Fibiger HC
J Pharmacol Exp Ther; 1997 Apr; 281(1):360-8. PubMed ID: 9103518
[TBL] [Abstract][Full Text] [Related]
18. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
[TBL] [Abstract][Full Text] [Related]
19. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
[TBL] [Abstract][Full Text] [Related]
20. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
Imperato A; Obinu MC; Casu MA; Mascia MS; Dazzi L; Gessa GL
J Pharmacol Exp Ther; 1993 Aug; 266(2):557-62. PubMed ID: 8102643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]